Latest News in the pharma Industry

All

Landmark Phase III trial shows fingolimod significantly reduces relapses in children and adolescents with MS

Landmark Phase III trial shows fingolimod significantly reduces relapses in children and adolescents with MS

6 Sep 2017

PARADIGMS is a first of its kind study in pediatric MS. Other current treatments have not been evaluated in head to head trials specifically designed for children and adolescents.

Read more 
Novartis CEO, Joseph Jimenez, to retire from Novartis in 2018

Novartis CEO, Joseph Jimenez, to retire from Novartis in 2018

5 Sep 2017

Vasant Narasimhan appointed CEO, effective 1February 2018.

Read more 
SGS Clinical Research strengthens its consultancy service to accelerate drugs through early phase development

SGS Clinical Research strengthens its consultancy service to accelerate drugs through early phase development

5 Sep 2017

Company consolidates its consultancy portfolio into a single, comprehensive offering.

Read more 
Catalent signs commercial manufacturing agreement with US WorldMeds for lofexidine

Catalent signs commercial manufacturing agreement with US WorldMeds for lofexidine

5 Sep 2017

Lofexidine is an investigational drug under development to mitigate symptoms associated with opioid withdrawal.

Read more 
Clintec expands UK headquarters and is presented with Queens Award for Enterprise – International Trade

Clintec expands UK headquarters and is presented with Queens Award for Enterprise – International Trade

5 Sep 2017

Company's additional 4327-sq ft floor at Clintec’s Glasgow-based headquarters forms a fully dedicated centre of excellence for clinical research and quality assurance capabilities.

Read more 
Takeda disappointed as NICE issue second negative draft decision for ixazomib

Takeda disappointed as NICE issue second negative draft decision for ixazomib

5 Sep 2017

Company says it is determined to work collaboratively to find a solution.

Read more 
Janssen enters exclusive distribution agreement for Invokana and Vokanamet

Janssen enters exclusive distribution agreement for Invokana and Vokanamet

4 Sep 2017

Distribution agreement covers countries in the EEA and Switzerland.

Read more 
Midatech submits MTD201 CTA filing for first in human study in carcinoid cancer and acromegaly

Midatech submits MTD201 CTA filing for first in human study in carcinoid cancer and acromegaly

4 Sep 2017

Midatech on track to start clinical development with MTD201 in Q4 2017.

Read more 
Welcome to the new CPhI-online.com

Welcome to the new CPhI-online.com

4 Sep 2017

Read more 
Prevent Lyme diseases – innovative tick solution!

Prevent Lyme diseases – innovative tick solution!

4 Sep 2017

Global emerging problem and new preventive solutions against tick-borne diseases from ICB Pharma- KICK THE TICK® expert.

Read more 
Unique formulation of Oseltamivir by BIOFARM

Unique formulation of Oseltamivir by BIOFARM

4 Sep 2017

BIOFARM Poland has been granted a patent for its own innovative formulation of tablets containing oseltamivir phosphate. Due to the unique, high concentration of the active substance, BIOFARM’s tablets are significantly smaller.

Read more 
3SBio accelerates expansion of its global biologics platform

3SBio accelerates expansion of its global biologics platform

3 Sep 2017

The Chinese biopharmaceutical company acquires the Canadian biomanufacturing business of Therapure.

Read more